We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.37B
1-Year Est. Return 71.68%
This Fund
S&P 500
This Quarter Est. Return
+23.86%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$1.37B
AUM Growth
+$61.8M
Cap. Flow
-$119M
Cap. Flow %
-8.67%
Top 10 Hldgs %
11.44%
Holding
1,623
New
447
Increased
343
Reduced
364
Closed
410

Top Buys

Rank Stock Value
1
JHG
Janus Henderson
JHG
+$11.4M
2
ROKU icon
Roku
ROKU
+$8.72M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.2M
4
ORCL icon
Oracle
ORCL
+$7.64M
5
NUVL
Nuvalent
NUVL
+$7.59M

Sector Composition

Rank Sector Weight
1 Technology 19.02%
2 Healthcare 12.44%
3 Industrials 12.15%
4 Consumer Discretionary 11.47%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSE icon
401
ADS-TEC Energy
ADSE
$842M
$724K 0.05%
56,814
MSCI icon
402
MSCI
MSCI
$39.3B
$720K 0.05%
+1,286
New +$750K
AZ icon
403
A2Z Smart Technologies
AZ
$247M
$720K 0.05%
123,706
+36,912
+43% +$252K
SMTC icon
404
Semtech
SMTC
$15.6B
$719K 0.05%
+4,442
New +$581K
INFQ
405
Infleqtion Inc
INFQ
$2.89B
$718K 0.05%
+53,884
New +$741K
SBUX icon
406
Starbucks
SBUX
$111B
$716K 0.05%
+7,003
New +$705K
TPR icon
407
Tapestry
TPR
$23.5B
$712K 0.05%
4,862
-2,193
-31% -$314K
ALM
408
Almonty Industries
ALM
$3.89B
$707K 0.05%
42,720
+3,555
+9% +$67.8K
TEL icon
409
TE Connectivity
TEL
$58.5B
$703K 0.05%
+3,487
New +$743K
CME icon
410
CME Group
CME
$98B
$700K 0.05%
3,169
+2,193
+225% +$607K
ROST icon
411
Ross Stores
ROST
$71.8B
$692K 0.05%
+3,252
New +$732K
NI icon
412
NiSource
NI
$19.5B
$684K 0.05%
14,382
+5,710
+66% +$270K
RGEN icon
413
Repligen
RGEN
$9.76B
$679K 0.05%
+4,975
New +$611K
ESPR
414
DELISTED
Esperion Therapeutics
ESPR
$675K 0.05%
213,636
+197,966
+1,263% +$554K
TSHA icon
415
Taysha Gene Therapies
TSHA
$1.65B
$670K 0.05%
+98,346
New +$582K
GRAB icon
416
Grab
GRAB
$11.7B
$668K 0.05%
177,084
+48,140
+37% +$175K
BTSG icon
417
BrightSpring Health Services
BTSG
$11.7B
$664K 0.05%
9,516
+719
+8% +$39.9K
COST icon
418
Costco
COST
$396B
$661K 0.05%
+707
New +$704K
PANW icon
419
Palo Alto Networks
PANW
$307B
$659K 0.05%
1,931
-6,842
-78% -$1.57M
LVS icon
420
Las Vegas Sands
LVS
$26.6B
$655K 0.05%
14,181
-5,822
-29% -$302K
NCLH icon
421
Norwegian Cruise Line
NCLH
$6.67B
$654K 0.05%
30,978
-8,307
-21% -$155K
CAH icon
422
Cardinal Health
CAH
$54.1B
$654K 0.05%
+2,752
New +$572K
IBKR icon
423
Interactive Brokers
IBKR
$39.3B
$652K 0.05%
7,494
+2,623
+54% +$218K
CTVA icon
424
Corteva
CTVA
$54B
$652K 0.05%
7,699
+2,635
+52% +$212K
LEGO.U
425
Legato Merger Corp IV Units
LEGO.U
$652K 0.05%
65,000

Similar funds

Prelude Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Prelude Capital Management held 1,623 positions worth $1.37B, up 4.7% from $1.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Prelude Capital Management withdrew a net $119M in Q2 2026, closing 410 positions and reducing 364 holdings. Its most notable exit was Clearwater Analytics, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Prelude Capital Management opened a new position in Vanguard S&P 500 ETF worth $8.44M.

  • Prelude Capital Management's largest Q2 2026 buy was Vanguard S&P 500 ETF: 12,295 shares worth $8.44M.
  • Prelude Capital Management added most to Janus Henderson in Q2 2026, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $25.1M.
  • Prelude Capital Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $14.7M.
  • Prelude Capital Management's ten largest holdings make up 11% of its $1.37B portfolio in Q2 2026.
  • Prelude Capital Management opened 447 new positions and closed 410 in Q2 2026.
  • Prelude Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.37B.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.